Diabetes mellitus, which is a common chronic disease in children, can lead to significant eye morbidities with long-lasting effects, including diabetic retinopathy. Treatment should be tailored to the individual patient.
Landmark randomised controlled trials have advanced the understanding and treatment of glaucoma.
Increasing understanding of the genetics behind Usher syndrome suggests that treatment may become possible in the very near future.
A global survey of retinal experts assessed their perceptions of evolving clinical practice in the Covid-19 era, focusing on digital teleophthalmology, home monitoring and decentralised patient care.
A look at what’s in the therapeutic delivery pipeline for these disorders.
Stromal regeneration seems possible in patients with keratoconus.
Look for fluctuating vision, test objectively and keep a few effective tools at your disposal to treat OSD.
A longitudinal, AI-based approach to fluid quantification
A greater understanding of lens embryology and the phenotype/genotype correlation of cataracts should help guide future therapeutic approaches.
The implantable lenses can offer an advantage over laser surgery
Topography-guided PRK, with or without the addition of corneal crosslinking, can improve visual acuity and quality in patients with keratoconus.
Newly developed acrylic implant provides option for patients with endothelial dysfunction.
Clinicians and surgeons should be aware of the misleading use of the EDOF concept. The authors herein propose an alternative terminology and that lenses which have combined optical designs are referred to as ‘hybrid IOLs’.
To date, the suprachoroidal space has not been a feasible route to reduce intraocular pressure in glaucoma. A new device promises to change that.
Two randomised controlled trials, EMGT and UKGTS, have examined the factors affecting the risk of glaucoma progression. Global target IOPs are not the best option for all patients.
Vitrectomy is a tool that can help surgeons curb complications
A new amblyopia screening system that can be used on Android devices has performed better than some of the ‘gold standard’ stereotests in recent Hungarian studies.
Ophthalmologists are seeking improved treatment options for uveitis as epidemiological studies demonstrate the scope and sight-stealing burden of the disease.
A new amblyopia screening system that can be used on Android devices has performed better than some of the ‘gold standard’ stereotests in recent Hungarian studies.
Presbyopia can be treated in emmetropic, myopic and hyperopic patients with refractive errors between +5.75 and -9.00 D using corneal non-linear aspheric ablation profiles to increase the depth of field in both eyes, in combination with micro-monovision. Patient satisfaction with this approach is high.
A corneal refractive technique can combine monovision and extended depth of field to create a wide, seamless range of functional vision. This can provide independence from spectacles.
Corneal cross-linking (CXL) is improving all the time, although all protocols retain the basic requirements for oxygen, riboflavin and UV light. Recent developments mean that CXL at the slit lamp is feasible, which will improve access to the procedure.
The Malyugin Ring 2.0 simplifies challenging cases of small pupils with zonulopathy by both stabilising the capsular bag and dilating the pupil.
Recent reports of retinal atrophy have raised concerns on potential long-term safety.